Pharmaceutical Technology

NOVEMBER 14, 2022

Such developments, including a 2021 approval of AstraZeneca’s Saphnelo (anifrolumab) , prompted The Lancet Rheumatology to posit that 2022 could be a “banner year” for the condition. The CAR-T therapies for conditions like lupus continue to look promising, but their safety is a concern, says Gilkeson. MSCs and CAR-Ts for lupus.

Side effects 144

Side effects Patients Manufacturing Safety 144

Pharmaceutical Technology

MAY 25, 2023

The results from a trial, published in The New England Journal of Medicine , found the vaccine was associated with a strong immune response and good safety profile. There was no significant difference in side effect profiles of the two vaccines, based on the data. percentage points (96% CI, −0.3 for serogroup W to 20.5

Side effects 78

Side effects Medicine Safety Marketing 78

Pharmaceutical Technology

MAY 26, 2023

The FDA first granted the drug under an emergency use authorisation (EUA) during the pandemic in December 2021. In response to the approval news, some pointed concerns about long-term safety. Paxlovid’s most common side effect is diarrhoea.

Food and Drug Administration 59

Food and Drug Administration FDA Side effects Safety 59

pharmaphorum

JULY 19, 2022

Steroids can be used to slow down progression of the condition, but can cause significant side effects if used too much and do nothing to restore the usual skin colour. Opzelura (ruxolitinib) is now the first alternative to steroid drugs for vitiligo, a chronic autoimmune disease that causes depigmentation of skin and affects around 1.5

FDA 94

FDA Side effects Sales Safety 94

pharmaphorum

JANUARY 3, 2023

The new pivotal study in TRS will run in parallel to Newron’s ongoing phase 3 trial (Study 008A) of evenamide versus placebo over four weeks in patients with schizophrenia, which started in September 2021 and is due to generate results in the first half of this year.

Side effects 104

Side effects Biopharma Patients Competition 104

European Pharmaceutical Review

JANUARY 25, 2024

Within the EU, patient information leaflets (PILs) are not merely a regulatory requirement but a cornerstone of patient safety. They detail the medication’s intended use, proper administration, potential side effects and precautions. percent as EU average with some Member States as high as 25 percent).

Healthcare 98

Healthcare Healthcare Safety Electronics 98

PM360

MAY 25, 2023

adults experienced mental illness in 2021, which represents about 1 in 5 adults or 57.8 This is different from clinical trials which are really designed to look at efficacy and safety in a very controlled environment, so controlled trials are very good at answering those two questions. million people.

Side effects 95

Side effects Medical Patients Networking 95

pharmaphorum

OCTOBER 27, 2022

It’s a disappointing outcome for a programme that GSK said in 2021 could potentially generate £1 to £2 billion in peak sales because of the serious unmet need in RA patients.

Side effects 78

Side effects FDA Patients Sales 78

European Pharmaceutical Review

JULY 5, 2022

There is an urgent need for more effective chemotherapy treatments with less severe toxicity and side effects. Irinotecan – also known by the brand name Campto/Camptosar ® (Pfizer Ltd.) – has proven to be an effective chemotherapy agent against several types of gastrointestinal cancer.

Patients 104

Patients Food and Drug Administration Side effects Safety 104

Clarify Health

AUGUST 1, 2023

In the United States, vaccine hesitancy is often observed among families with lower levels of education, lower socioeconomic status, and concerns about vaccine safety and side effects Addressing concerns and providing accurate information to counter misinformation are crucial steps to overcome vaccine hesitancy.

Safety 52

Safety Education Healthcare Healthcare 52

Impetus Digital

AUGUST 2, 2024

Unsurprisingly, the US FDA has reported a noticeable increase in the number of submissions that use AI/machine learning (ML) components in recent years; in 2021, they received more than 100 submissions wherein AI use was reported. In 2022, the AI-fuelled pipeline reportedly expanded at an annual rate of almost 40%.

Pharma 95

Pharma Manufacturing Medicine Marketing 95

European Pharmaceutical Review

AUGUST 15, 2024

BTKis, oral drugs given as continuous monotherapy, have revolutionised the treatment of CLL, with the first generation BTKi ibrutinib receiving European Medicines Agency (EMA) approval in 2014; however, side-effects (such as cardiovascular toxicities 2 ) have limited its suitability. for all-comers; HR=0.52

Safety 52

Safety Patients Medical Medicine 52

pharmaphorum

SEPTEMBER 12, 2022

CodeBreak-200 will nevertheless likely serve as a confirmatory study for the approval of Lumakras (sotorasib) in this heavily pretreated patient population, which was granted by the FDA in May 2021.

Side effects 52

Side effects FDA Patients Safety 52

Contrarian Sales Techniques

FEBRUARY 26, 2023

Pharmaceutical experts have spoken about four aspects that generic manufacturers must take into account when purchasing active pharmaceutical ingredients, such as cost, quality, availability, quality control, and safety. Indian and Chinese companies that produce high-quality generic medicines and export them around the world are competing.

Pharmaceutical 52

Pharmaceutical Medicine Government Manufacturing 52

European Pharmaceutical Review

SEPTEMBER 22, 2023

While new positive clinical data with anti-Abeta mAbs signal tremendous advancement and proof‑of-concept for the whole field, it is believed that the observed effects could still be improved and optimised in terms of greater clinical benefits, lower side effects and enhanced treatment convenience.

Food and Drug Administration 97

Food and Drug Administration Safety Patients Leads 97

PM360

AUGUST 9, 2022

According to an August 2021 report from the Business Research Company , after experiencing a decline in 2020 due to pandemic, the medication adherence market is expected to recover and grow at a compound annual growth rate (CAGR) of 11.4% from 2021 and reach $4.2 In fact, the number of new solutions just keeps growing every year.

Prescription 105

Prescription Medical Patients Side effects 105

Pharmaceutical Technology

JANUARY 25, 2023

By selectively degrading these proteins, PROTACs have the potential to effectively treat a range of diseases with potentially fewer side effects compared to traditional approaches. Syngene is setting up the predictive models and new platforms to overcome these challenges.”

Side effects 52

Side effects Leads Safety Manufacturing 52

European Pharmaceutical Review

DECEMBER 27, 2023

4 Manufacturing of CAR T-cell therapies: an overview In addition, multi-disciplinary teams must be established for in-house CAR T-cell therapy programmes to ensure maximum success and safety. After this incident CAR-related toxicity scales and guidelines were established to prevent adverse reactions. 2022;140(Supplement 1):4633–5.

Manufacturing 104

Manufacturing Food and Drug Administration Patients Pharma 104

Contrarian Sales Techniques

FEBRUARY 10, 2023

They are designed to be safe and comfortable for patients, and typically have minimal side effects. According to various market research reports, the global non-invasive medical devices market was valued at approximately USD 45 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of over 6% from 2021 to 2028.

Healthcare 52

Healthcare Healthcare Manufacturing Medical 52

Pharmaceutical Representative Training

OCTOBER 9, 2024

They may have valid concerns about the product’s cost, potential side effects, or its suitability for their patients. There are four main categories of objections, known as PETE: Price, Effort, Time, and Effectiveness. 2021, December 17). Secondly, budget constraints are also a common objection in pharma sales. “The

Sales 52

Sales Pharma Pharmaceutical Sales Prospecting 52

PM360

AUGUST 9, 2022

According to the 2021 Accenture Healthcare Experience Survey, 52% of patients say having emotional support is important to having a positive healthcare experience. Accordingly, multiple reasons for subpar patient adherence are gaining attention, including fear of side effects, lack of medical understanding, or even financial limitations.

Medical 105

Medical Patients Electronics Healthcare 105

PM360

JULY 13, 2023

Launched in 2021, Adheris Health’s intelligent patient platform, THRiV, translates these patient insights into actions. In 2021, IQVIA In Home Clinical Solutions pioneered an innovative program to address the challenge patients with breast cancer faced when trying to adhere to their treatment which required frequent ECG testing.

Education 89

Education Medical Patients Media 89

European Pharmaceutical Review

OCTOBER 3, 2024

It is highly selective and has shown an excellent safety and tolerability profile to date. Advancements in oral small molecule drug development can be attributed to significant technological improvements, particularly in screening methodologies, including AI -driven approaches, which help identify and profile drugs more effectively.

Safety 52

Safety Pharmaceutical Patients Side effects 52

PM360

JUNE 11, 2022

Only 5% of patients ranked pharma companies as the most trusted player in the healthcare space, according to a 2021 survey of 500 patients from Accenture. These topics might include side effect management, patient compliance, and needs for other resources such as mental healthcare, general wellness, etc.

Patients 59

Patients Pharma Education Media 59

Pharmaceutical Technology

OCTOBER 10, 2022

Despite the recognized need and demand for options to treat female sexual dysfunction, several safety and access issues associated with the use of available options. Overall, side effects serve as a more significant barrier in this condition than elsewhere because the condition is not life-threatening, says Ben-Zion.

Pharmacology 59

Pharmacology Side effects FDA Safety 59

Pharmaceutical Technology

FEBRUARY 17, 2023

In January, amidst calls to improve patient safety by optimizing licensed drug formulations, the FDA released a draft guidance that signalled a departure from the most commonly used method of identifying a new therapy’s ideal dosage. The focus on identifying the ideal drug dosage is not new.

FDA 115

FDA Side effects Pharmacology Patients 115

Pharmaceutical Technology

MAY 31, 2023

The Danish CRISPR biotech SNIPR BIOME has released the first glimpse at the safety profile for SNIPR001, a gene therapy intended to target antibiotic resistance. Interim clinical results from a Phase I trial have demonstrated SNIPR001’s safety in healthy volunteers. Free Report How is the Biopharmaceutical industry evolving?

Food and Drug Administration 98

Food and Drug Administration Safety Side effects FDA 98

Nixon Gwilt Law

NOVEMBER 5, 2021

On November 2, 2021, the Centers for Medicare and Medicaid Services (“CMS”) finalized the Medicare Physician Fee Schedule for Calendar Year 2022 (the “Final 2022 MPFS” or the “Final Rule”). TL;DR: CMS adopted, as proposed, its audio-only telemental health provisions, and declined to make a determination on remote direct supervision.

Physicians 52

Physicians Professional Services Medical Side effects 52

Pharmaceutical Technology

JANUARY 22, 2023

Dr. Jerry Mendell, MD, professor of paediatrics and neurology at the Ohio State University College of Medicine, is optimistic for its approval and says the drug has a good safety profile. However, before the drug can receive an approval, Santhera will have to overcome doubts about vamorolone’s safety. compared to 38.5% on placebo.

FDA 126

FDA Safety Pharmaceutical Patients 126

Pharmaceutical Technology

JUNE 5, 2023

With a higher expression of PD-1 and VEGF in tumour tissue and the tumour microenvironment, Summit claims that ivonescimab can more effectively target tumour tissue to provide safer treatment with fewer side effects. The treatment had an acceptable safety profile in combination with chemotherapy.

Side effects 52

Side effects Patients Leads Prospecting 52

Pharmaceutical Technology

MAY 31, 2023

The document would include the drug/biological product name, side effects, directions for use, safety information, and a concise summary of indications and uses. 2021 was a year of continued innovation and change in the Biopharmaceutical industry. Free Report How is the Biopharmaceutical industry evolving?

Prescription 52

Prescription FDA Food and Drug Administration Medical 52